Back to Search

ZELALEM TEMESGEN, M.D.

M.D.

Infectious Disease Physician

NPI: 1528030335IndividualAccepts Medicare

Specialties, Licenses & Credentials

Infectious Disease PhysicianPrimary

Internal Medicine — Infectious Disease

Code: 207RI0200X

35857(MN)

CMS Specialties

Education

OTHER

Class of 1986

Research & Publications (20)

Raltegravir: first in class HIV integrase inhibitor.
PMID 18728839·Ther Clin Risk Manag·2008
8-other
Advances in antiretroviral therapy.
PMID 18389104·Drug News Perspect·2008
8-other
The latest in antiretroviral therapy.
PMID 17160151·Drug News Perspect·2006
8-other
Drug evaluation: bevirimat--HIV Gag protein and viral maturation inhibitor.
PMID 16955688·Curr Opin Investig Drugs·2006
6-review
Current status of antiretroviral therapy.
PMID 16872258·Expert Opin Pharmacother·2006
6-review
Tipranavir.
PMID 16395412·Drugs Today (Barc)·2005
6-review
[Bone and joint involvement in human immunodeficiency virus infection].
PMID 16105502·Acta Chir Orthop Traumatol Cech·2005
6-review
HIV and drug allergy.
PMID 15242725·Immunol Allergy Clin North Am·2004
6-review
Initial antiretroviral therapy in chronically-infected HIV-positive adults.
PMID 15013928·Expert Opin Pharmacother·2004
6-review
Current status of antiretroviral therapies.
PMID 11584991·Expert Opin Pharmacother·2001
6-review
Lung infections after cancer chemotherapy.
PMID 19071255·Lancet Oncol·2008
6-review
Perspectives in therapy for hepatitis C.
PMID 18922100·Expert Opin Investig Drugs·2008
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
200 1ST ST SW
ROCHESTER, MN 55905

Quick Facts

NPI
1528030335
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
40
Publications
20

Are you this provider?

Claim Your Profile